Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Sharp Edge Labs
company
About
Sharp Edge Labs is engaged in the development of biosensors for cellular biology research and high-throughput screening.
- 1 - 10
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $600K
- Industries
- Biotechnology,Life Science,Medical Device
- Founded date
- Jan 1, 2010
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Sharp Edge Labs, Inc. engages in developing biosensors for cellular biology research and high-throughput screening. The company’s products include targeted biosensors to the cellular biology research community. It offers its products based on the fluorogenic activating proteins that provide a detection method for cellular changes, which is amendable to high-throughput screening and follow-up. The company was incorporated in 2011 and is based in Pittsburgh, Pennsylvania.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$600K
Sharp Edge Labs has raised a total of
$600K
in funding over 2 rounds. Their latest funding was raised on
Aug 19, 2014 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 19, 2014 | Series B | $600K | 1 |
Newlin Investment Company
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Sharp Edge Labs is funded by 1 investors.
Newlin Investment Company
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Newlin Investment Company
|
Yes | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
